ImageneBio (IMA) Non Operating Income (2020 - 2025)

ImageneBio has disclosed Non Operating Income across 6 years of filings, most recently posting $1.8 million for Q3 2025.

• Non Operating Income for Q3 2025 came in at $1.8 million, up 253.98% year-over-year; the trailing twelve-month figure through Sep 2025 was $17.3 million (up 565.64% YoY), and the FY2024 annual result was $9.9 million, up 45059.09% from the prior year.
• Non Operating Income came in at $1.8 million for Q3 2025 at ImageneBio, down from $4.7 million in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $10.8 million in Q4 2024 to a low of -$4.9 million in Q4 2023.
• The 5-year median for Non Operating Income is $7000.0 (2021), against an average of $885421.1.
• Across the five-year window, Non Operating Income jumped 20240.0% in 2022 and slumped 59550.0% in 2024, its largest moves.
• ImageneBio's Non Operating Income stood at $5000.0 in 2021, then surged by 20240.0% to $1.0 million in 2022, then tumbled by 577.29% to -$4.9 million in 2023, then surged by 322.27% to $10.8 million in 2024, then plunged by 82.97% to $1.8 million in 2025.
• The last three Non Operating Income figures came in at $1.8 million (Q3 2025), $4.7 million (Q2 2025), and -$82000.0 (Q1 2025), per Business Quant data.